How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines

Clinical Science

Volumn 94, Issue 6, 1998, Pages 591-599

  Missouris, Constantinos G ^a   Grouzmann, Eric ^b   Buckley, Martin G ^a,c   Barron, Jeffrey ^d   Macgregor, Graham A ^a   Singer, Donald R J ^a,c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Catecholamines; Heart failure; Natriuretic peptides; Neuropeptide Y; Renin angiotensin aldosterone system

Indexed keywords

ADRENALIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE DERIVATIVE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN; NEUROPEPTIDE Y; NORADRENALIN; RENIN;

ACUTE HEART FAILURE; ADRENALIN BLOOD LEVEL; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031835623     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940591     Document Type: Article

References (46)

1. Packer M. (1992) Pathophysiology of chronic heart failure. Lancet 340: 88-92.
2. Burnett JC, Kao PC, Hu DC, et al. (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (Washington DC) 231: 1145-7.
3. Mukoyama M, Nakao K, Hosoda K, et al. (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 87: 1402-12.
4. Lang CC, Coutie WJ, Khong TK, Choy AMJ, Struthers AD. (1991) Dietary sodium loading increases plasma brain natriuretic levels in man. J Hypertens 9: 779-882.
5. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DRJ, MacGregor GA. (1992) Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with chronic renal failure. Clin Sci 83: 437-44.
6. Yoshimura M, Yasue H, Morita E, et al. (1991) Haemodynamic, renal and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84: 1581-8.
7. Motwani JG, McAlpine H, Kennedy N, Struthers AD. (1993) Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 341: 1109-13.
8. Arakawa N, Nakamura M, Aoki H, Hiramori K. (1996) Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27: 1656-61.
9. Omland T, Aakvaag A, Bonarjee VVS, et al. (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal pro-atrial natriuretic peptide. Circulation 93: 1963-9.
10. Thomas PS. (1996) Raised brain natriuretic peptide in pulmonary hypertension. Respir Med 90: 247-9.
11. Anderson JV, Woodruff PW, Bloom SR. (1988) The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br Heart J 59: 207-11.
12. Bayliss J, Norrell M, Canepa-Ansor R, Sutton G, Poole-Wilson P. (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17-22.
13. Dzau VJ, Packer LS, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. (1984) Prostaglandins in severe heart failure: relation to activation of the renin-angiotensin system and hyponatraemia. N Engl J Med 310: 347-52.
14. Feng QP, Hedner T, Andersson B, Lundberg SM, Waagstein V. (1994) Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J 71: 261-7.
15. Singer DRJ, Markandu ND, Buckley MG, et al. (1994) Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients: implications for the control of sodium balance. Circulation 89: 1153-9.
16. Grouzmann E, Aubert JF, Waeber B, Brunner HR. (1992) A sensitive and specific two-site, sandwich amplified enzyme immunoassay for neuropeptide Y. Peptides 13: 1049-54.
17. Causon RC, Carruthers ME, Rodnight R. (1981) Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal Biochem 116: 223-6.
18. Pombo JF, Russell ROJ, Rackley CE. (1971) Comparison of stroke volume and cardiac output determination by ultrasound and dye dilution in acute myocardial infarction. Am J Cardiol 27: 630-5.
19. Anand IS, Ferrari R, Kalra GS, Wadi PW, Poole-Wilson PA, Harris PC. (1989) Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes and plasma hormones in untreated congestive heart failure. Circulation 80: 299-305.
20. Dzau VJ, Colucci WS, Hollenberg NK. (1981) Relation of the renin-angiotensin-aldosterone system to the clinical state in congestive heart failure. Circulation 63: 645-51.
21. Anand IS, Kalra GS, Ferrari R, Wahi PL, Harris PC, Poole-Wilson PA. (1990) Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Int J Cardiol 28: 341-6.
22. Ferrari R, Anand IS, Ceconi C, de Giuli F, Poole-Wilson PA, Harris P. (1996) Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis. Heart 76: 50-5.
23. Opgenorth TJ, Burnett JC, Granger JP, Scriven TA. (1986) Effects of atrial natriuretic peptide on renin secretion in non-filtering kidney. Am J Physiol 250: F798-801.
24. Singer DRJ, Markandu ND, Buckley MG, Miller MA, Sagnella GA, MacGregor GA. (1991) Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension. Hypertension 18: 798-004.
25. Saito Y, Nakao K, Nishimura K, et al. (1987) Clinical applications of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76: 115-24.
26. Walker P, Grouzemann E, Burnier M, Waeber B. (1991) The role of neuropeptide Y in cardiovascular regulation. TIPS 12: 111-15.
27. Waeber B, Aubert JF, Corder R, Evequoz D, Nussberger J, Gaillard R, Brunner HR. (1988) Cardiovascular effects of neuropeptide Y. Am J Hypertens 1: 193-9.
28. Allen JM, Gjorstrup P, Bjorkman J-AE, Abrahamsson T, Bloom SR. (1986) Studies on cardiac distribution of neuropeptide Y. Acta Physiol Scand 126: 405-11.
29. Clarke JG, Davies GJ, Kerwin R, et al. (1987) Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet ii: 1057-9.
30. Franco-Cereceda A, Lundberg JM, Dahlof C. (1985) Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol Scand 124: 361-9.
31. Hulting J, Sollevi A, Ullman B, Franco-Cereceda A, Lundberg JM. (1990) Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc Res 24: 102-8.
32. Dubois-Rande JL, Comoy E, Merlet P, et al. (1992) Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure. Eur Heart J 13: 1233-8.
33. Masden BK, Husum D, Videbaek R, Stkholm KH, Saelsen L, Christensen NJ. (1993) Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise. Scand J Clin Lab Invest 53: 569-76.
34. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall cardiorenal sympathetic nervous activity. Circulation 73: 615-21.
35. Euler USV, Franksson C, Hellstrom J. (1954) Adrenaline and noradrenaline output in urine after unilateral or bilateral adrenalectomy in man. Acta Physiol Scand 31: 1-6.
36. Christensen NJ, Brandsborg O. (1973) The relationship between plasma catecholamine concentration and pulse rate during exercise and standing. Eur J Clin Invest 3: 299-306.
37. Esler M, Jennings G, Korner P, et al. (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11: 3-20.
38. Lake CR, Ziegler MG, Kopin IJ. (1976) Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci 18: 1315-26.
39. Francis GS, Benedict C, Johnstone DE, et al. (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-9.
40. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G. (1986) Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-9.
41. Hasking GJ, Esler MD, Jennings GL, Dewar E, Lambert G. (1988) Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation 78: 516-21.
42. Gaffney TE, Braunwald E. (1962) Importance of the adrenergic nervous system in support of circulatory function in patients with congestive heart failure. Am J Med 34: 320-4.
43. Bristow MR, Minobe W, Rasmussen R, et al. (1992) Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89: 803-15.
44. Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan EDJ. (1987) Reversibility of catecholamine-induced dilated cardiomyopathy in a child with pheochromocytoma. N Engl J Med 316: 793-7.
45. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN. (1987) Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J 114: 148-52.
46. SHEP-Cooperative-Research-Group. (1991) Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255-64.